Excerpts

In another retrospective study, Park et al., found a signi fi cantly higher proportion of patients developing radionecrosis in the group receiving more than one HER2-directed agent, but no significant difference was apparent when comparing patients with one or no HER2-directed agent during SRT [ 108 ].

At the same time, it is necessary to note that the mortality rate for almost all types of cancer in China’s elderly population (over 70 years of age) has shown an increasing trend over the past three decades. 3.3.

Finally, we studied the pan-cancer application prospects of FBLN5 in targeted therapy and performed a tumor purity analysis ( Figure 7 F), TMB analysis ( Figure 7 G), and MSI analysis ( Figure 7 H), and found that the expression of FBLN5 showed a trend of negative correlations with TMB and MSI, which proved that targeted therapy was not supported when FBLN5 expression was high.

The FBLN5 expression level in patients showed an increasing trend with an increase in tumor progression, lymph node metastasis, and pTNM stage, and the patient prognosis was poor, which suggests that FBLN5 might be a biomarker of tumor progression.

Age showed a trend toward differentiation but did not reach statistical significance.

However, there was a clear trend for increased OS if patients were grouped in negative (less than 1%) vs. positive (more than 1%) PD-L1 irrespectively of the level of positiveness. 3.2.2.

showed an increased risk (nearly statistically significant) of repeated occurrence of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) with a longer duration of thiopurines treatment (>1 year) after the NMSC diagnosis, not before [ 40 ].

Moreover, OS evaluation in the three risk groups showed a trend coherent with TO achievement probability.

showed a trend for increasing SUVmax values from Luminal A (lower values) to Luminal B HER2-positive type and HER2-enriched tumors (higher values); moreover, HER2 expression seems to confer the highest 68 Ga-FAPI activity among the Luminal group, with significantly higher uptake in Luminal B HER2-positive vs.

On the other hand, lymphoma patients mobilized without Plerixafor showed a trend to faster engraftment.

The differences in the content of markers between groups were statistically significant or nearly significant (as in the cases of CD8 + and CD1a + ).

However, there is a worrying trend towards a rapidly increasing incidence of BCC in the age group of population under 40 years, especially in women [ 6 ].

A negative trend exists between EPHA3 expression and neutrophil infiltration, as well as the neutrophil markers (CD15 and CD11b), which indicates that EPHA3 might be correlated with neutrophil activation.

Patient Age and the Likelihood of Recovery—Is There Any Connection? A possible trend towards faster recovery in the younger patients of our series could favor plasticity as a key mechanism of recovery.

The result indicated a marginal trend that the ER signaling played a protective role in PAAD. 3.4.

[ 33 ] confirmed a significant trend to PTLN metastasis for advanced cT hypopharyngeal cancers.

There was a highly significant positive correlation between the two miRNAs in the TCGA-PRAD biopsy data corroborating a role for miR-21 in the hypoxic response in prostate cancer ( Figure 2 E).

In addition, the other two NR4A family members, NR4A1 and NR4A3, showed a trend of similar regulation, although not fulfilling significant regulation for both criterias (females vs. males and pre- vs postmenopausal females) when analyzing the RNA-seq data.

In the first line setting, the HR was 0.34 (95% CI, 0.16–0.72) with a p value of 0.054, a trend for benefit of borderline significance.

These findings are extremely significant, since they suggest that higher blood glucose levels, which may be related to the need for more energy expenditure to express high pancreatic cancer lesions, promote the elevated expression of RBM15 in pancreatic cancer.

Although our analysis by periods showed—through an internal and external comparison—a decreasing trend in the incidence of all cancers combined among KT recipients, we found no significant changes in the incidence over time for the major cancer types, with the exception of Kaposi’s sarcoma.

Unexpectedly, ADH5 was significantly upregulated in primary melanoma samples of one dataset and showed an increasing trend in melanoma in the other two datasets ( Figure 3 e, left).

Although HER2-positive AAC showed a trend towards shorter survival, it was not statistically significant.

PSMA-TLQ measurement differences gave a borderline significance with a p -value of exactly 0.05.

Surprisingly, our data also show discordance between the overall response rate and PFS as there was no improvement in the depth of response in our meta-analysis, even with an anti-CD38 containing regimen, while we detected a highly significant PFS advantage with the use of daratumumab.